Table 2. Multivariable Poisson Regression Models Reporting RRs of Longer-Term COVID-19 Symptoms Reported 28 or More Days or 90 or More Days After Symptom Onset.
Variable | ≥28 d (n = 1807) | ≥90 d (n = 1726) | ||
---|---|---|---|---|
RR (95% CI) | P value | RR (95% CI) | P value | |
Unvaccinated prior to infection | 1.39 (1.04-1.85) | .02 | 1.37 (0.88-2.13) | .17 |
Delta variant perioda | 0.92 (0.71-1.20) | .53 | 0.68 (0.46-1.02) | .07 |
Maximum symptom severity during acute illness | ||||
None or mild | 1 [Reference] | NA | 1 [Reference] | NA |
Moderate | 1.80 (1.47-2.22) | .00 | 2.19 (1.62-2.96) | .00 |
Severe or critical | 2.25 (1.80-2.81) | .00 | 2.88 (2.09-3.97) | .00 |
Days hospitalizedb | 1.02 (1.00-1.03) | .01 | 1.02 (1.00-1.03) | .03 |
Reported respiratory symptoms on enrollment form | 1.14 (0.97-1.34) | .11 | 0.96 (0.76-1.20) | .70 |
Age group, y | ||||
18-44 | 1 [Reference] | NA | 1 [Reference] | NA |
45-64 | 1.02 (0.81-1.30) | .85 | 1.10 (0.79-1.53) | .57 |
≥65 | 0.93 (0.62-1.41) | .74 | 1.20 (0.68-2.12) | .53 |
Sex | ||||
Female | 1.13 (0.97-1.31) | .11 | 1.20 (0.97-1.48) | .09 |
Male | 1 [Reference] | NA | 1 [Reference] | NA |
Charlson Comorbidity Index score | ||||
0 | 1 [Reference] | NA | 1 [Reference] | NA |
1-2 | 1.07 (0.83-1.38) | .59 | 0.85 (0.59-1.21) | .37 |
3-4 | 1.02 (0.68-1.53) | .91 | 0.80 (0.45-1.41) | .44 |
≥5 | 1.55 (1.01-2.37) | .046 | 1.25 (0.69-2.26) | .46 |
BMI categoryc | ||||
Underweight or normal weight | 1 [Reference] | NA | 1 [Reference] | NA |
Overweight | 1.03 (0.84-1.26) | .77 | 0.98 (0.74-1.29) | .87 |
Obesity | 0.95 (0.76-1.19) | .64 | 0.90 (0.66-1.23) | .51 |
Severe obesity | 1.04 (0.81-1.35) | .74 | 1.12 (0.79-1.59) | .51 |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); NA, not applicable; RR, risk ratio.
July 1 to December 31, 2021.
The RRs reported are per day of hospitalization.
Underweight or normal weight was defined as less than 25; overweight, 25 to 29; obesity, 30 to 34; and severe obesity, 35 or higher.